ENaC-α has established roles in the development of acute respiratory distress syndrome (ARDS) mediated through immune cell activation and cytokines/chemokines (42, 43), indicating that this mechanism may have a role in the pathogenesis of ARDS in severe COVID-19 patients. The gene discussed is SCNN1A; the disease is acute respiratory distress syndrome.